By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


GenomeDx Biosciences 

400 – 311 Water Street

Vancouver  British Columbia  BC V6B 1B8  Canada
Phone: 1-888-975-4540 Fax: n/a



Company News
Data Presented At 2015 ASCO Genitourinary Symposium Compares, Validates And Demonstrates Utility For GenomeDx Biosciences's Decipher Test 2/24/2015 10:04:35 AM
GenomeDx Biosciences's Decipher Shows Broad Applicability In Advancing Prostate Cancer Care In Data Presented At 2015 ASCO Genitourinary Symposium 2/24/2015 7:55:12 AM
GenomeDx Biosciences Release: Study Published In Journal Of Clinical Oncology Finds That The Decipher Prostate Cancer Test Predicts Which Patients Benefit from Radiation Therapy Following Prostate Surgery 2/10/2015 7:26:11 AM
GenomeDx Biosciences Implements Clarity LIMS For Use In Clinical Lab 1/20/2015 8:56:23 AM
GenomeDx Biosciences Secures Medicare Coverage For Decipher® Prostate Cancer Test 1/15/2015 10:08:00 AM
GenomeDx Biosciences Release: Study Published In European Urology Shows That The Decipher Prostate Cancer Classifier Is Predictive Of Rapid Metastasis In High-Risk Men Who Have Had Prostate Surgery 12/22/2014 8:06:39 AM
GenomeDx Biosciences And Mayo Clinic Enter Agreement To Conduct Validation Study Of Decipher® Prostate Cancer Test In Patients Receiving Biopsy Prior To Treatment 11/11/2014 7:26:05 AM
GenomeDx Biosciences Adds A National PPO To Make Available Decipher® Prostate Cancer Test 9/25/2014 8:21:12 AM
GenomeDx Biosciences Announces Presentation Of Positive Results From New Validation Study For Decipher® At The Annual Meeting Of The American Society For Radiation Oncology (ASTRO) In San Francisco 9/18/2014 8:17:44 AM
Improving Cancer Treatment Decisions With Genomic Data, GenomeDx Biosciences Reveals 9/5/2014 8:13:56 AM